信邦制药: 半年报董事会决议公告

Meeting Overview - The ninth board meeting of Guizhou Xibang Pharmaceutical Co., Ltd. was held on August 28, 2025, in a combined onsite and remote format, with all 8 directors present [1] - The meeting was legally convened and conducted in accordance with relevant laws and regulations [1] Resolutions Passed - The board unanimously approved the profit distribution plan for the first half of 2025, considering the company's profitability and overall financial status [2] - The proposal to amend relevant provisions of the company's articles of association was also approved [2][3] - The company plans to abolish the supervisory board, transferring its responsibilities to the audit committee of the board, pending approval from the shareholders' meeting [3] - Several governance system revisions were approved to enhance operational standards and governance effectiveness [4] Future Actions - All resolutions, including the profit distribution plan and governance amendments, are subject to approval at the company's first extraordinary general meeting of 2025 [2][3][4] - The company has announced the convening of the first extraordinary general meeting of 2025 [4][6]